© BusinessWire
31.10.2025
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
BAVA
LISTED
CPH
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
News Preview
COPENHAGEN, Denmark, October 31, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 4.99% of the shares and voting rights in Bavarian Nordic A/S as of October 27, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
BAVA
LISTED
CPH
Bavarian Nordic shareholders are reminded of expiry of the offer period regarding the takeover offer from consortium consisting of Nordic Capital and Permira
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
31.10.2025
ZLAB
LISTED
NASDAQ
Zai Lab Announces Participation in Investor Conferences in November and December 2025
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in November and December 2025:
Jefferies Global Healthcare Conference in London
Fireside Chat: Wednesday, November 19, 2025 at 8:30AM GMT
Location: London
Citi's 2025 Global Heal...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
31.10.2025
KDEV
LISTED
STO
Karolinska Development’s portfolio company BOOST Pharma presents positive long-term data for its cell-based treatment of Osteogenesis imperfecta
News Preview
STOCKHOLM, SWEDEN, October 31, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company BOOST Pharma has presented new long-term data from the BOOSTB4 phase 1/2 trial with the company’s cell therapy BT-101 targeting the rare bone disease Osteogenesis imperfecta. The new results comprise two-year follow-up...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
BAVA
LISTED
CPH
Bavarian Nordic Awarded New Procurement Framework Contract by the European Commission to Strengthen Preparedness Against Smallpox and Mpox
News Preview
COPENHAGEN, Denmark, October 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today the award of a joint procurement contract by the European Commission, through the Health Emergency Preparedness and Response Authority (HERA), enabling the EU, its member states and additional European countries1 to purchase up to 8 million doses of the Company’...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
NKTR
LISTED
NASDAQ
Nektar Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
News Preview
SAN FRANCISCO, Oct. 30, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that company management will be webcasting its participation in the Jefferies Global Healthcare Conference being held November 17-20, 2025 in London....
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
DFTX
LISTED
NASDAQ
MindMed to Report Q3 2025 Financial Results on November 6, 2025
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it will host a live webcast at 4:30 p.m. EST on Thursday, November 6, 2025 to report financial results for the third quarter ended Septem...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
DBV
LISTED
EURONEXT
DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors
News Preview
Châtillon, France, October 30, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
OSE
LISTED
EURONEXT
Informations relatives au nombre total de droits de vote et d’actions composant le capital
News Preview
Informations relatives au nombre total de droits de vote et d’actions
composant le capital...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
CYRX
LISTED
NASDAQ
Cryoport Continues to Set New Benchmarks for the Global Regenerative Medicine Supply Chain
News Preview
First Global Supply Chain Solutions Company to Achieve
ISO 21973
Certification, Ensuring Highest Transport Safety, Traceability, and Integrity Standards for Cell and Gene Therapies
NASHVILLE, Tenn., Oct. 30, 2025 /PRNewswir...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ORY
LISTED
BME
ORYZON to Participate in Upcoming Events in November
News Preview
MADRID, Spain and CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics, announced today that its management will participate at the following upcoming events:...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
30.10.2025
BIOA B
LISTED
STO
Sales of Leqembi® totaled 18 billion yen in the third quarter 2025
News Preview
STOCKHOLM, Oct. 30, 2025 /PRNewswire/ -- BioArctic AB's (publ) (STO: BIOA B) partner Eisai today published the preliminary global revenue for Leqembi during the third quarter 2025, in conjunction with their partner Biogen's third quarter report. In total, sales of JPY 18 billion were recorded in the period. This...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
AMRX
LISTED
NASDAQ
Amneal Reports Third Quarter 2025 Financial Results
News Preview
‒ Q3 2025 Net Revenue of $785 million; GAAP Net Income of $2 million; Diluted Income per Share of $0.01 ‒‒ Adjusted EBITDA of $160 million; Adjusted Diluted EPS of $0.17 ‒‒ Updated 2025 Full Year Guidance ‒...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
HNSA
LISTED
STO
Hansa Biopharma Reports Third Quarter and Interim Year to Date 2025 Financial Results
News Preview
Imlifidase successfully met primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation.
First clinical data supports imlifidase ability to substantially reduce anti-AAV antibodies to allow administration of gene t...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
HNSA
LISTED
STO
Hansa Biopharma Reports Third Quarter and Interim Year to Date 2025 Financial Results
News Preview
Imlifidase successfully met primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation.
First clinical data supports imlifidase ability to substantially reduce anti-AAV antibodies to allow administration of gene t...
Themefolio
Profiler
Peergroup
© EQS Newswire
30.10.2025
FYB
LISTED
XETR
Formycon invites to Conference Call on 2025 Nine-Month Results and announces Participation in Investor Conferences in the 4th Quarter of 2025
News Preview
Press Release // October 30, 2025
Formycon invites to Conference Call on 2025 Nine-Month Results and announces Participation in Investor Conferences in the 4th Quarter of 2025
Planegg-Martinsried, Germany – Formycon AG (FSB: FYB, Prime Standard, „Formycon“) plans to publish its Nine-Month Results 2025 on November 13, 2025. The Management Boar......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.10.2025
FYB
LISTED
XETR
Formycon lädt zur Telefonkonferenz zum Neunmonatsergebnis 2025 ein und gibt Teilnahme an Investorenkonferenzen im 4. Quartal 2025 bekannt
News Preview
Pressemitteilung // 30. Oktober 2025
Formycon lädt zur Telefonkonferenz zum Neunmonatsergebnis 2025 ein und gibt Teilnahme an Investorenkonferenzen im 4. Quartal 2025 bekannt
Planegg-Martinsried – Die Formycon AG (FWB: FYB, Prime Standard, „Formycon“) plant die Neunmonatszahlen 2025 am 13. November 2025 zu veröffentlichen. Der Vorstand wird di......
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
DFTX
LISTED
NASDAQ
Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the pricing of an underwritten public offering of 18,375,000 common shares, without par value, at a public offering price of $12.25 per common...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
DBV
LISTED
EURONEXT
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
News Preview
Châtillon, France, October 29, 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
DFTX
LISTED
NASDAQ
Mind Medicine (MindMed) Inc. Announces Proposed Public Offering
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it intends to offer and sell, subject to market conditions, common shares and, to certain investors, pre-funded warrants to purchase comm...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
HNSA
LISTED
STO
Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results
News Preview
LUND, Sweden, Oct. 29, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host a virtual event featuring two distinguished transplant surgeons; Professor Robert Montgomery from NYU Langone Transplant Institute and Professor Matthew Cooper from the Medical Colleg...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
HNSA
LISTED
STO
Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results
News Preview
LUND, Sweden, Oct. 29, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host a virtual event featuring two distinguished transplant surgeons; Professor Robert Montgomery from NYU Langone Transplant Institute and Professor Matthew Cooper from the Medical Colleg...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
UCB
LISTED
EURONEXT
UCB opens applications for 2026 UCB Myasthenia Gravis Scholarship™
News Preview
ATLANTA, Oct. 29, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced the opening of applications for the second annual UCB U.S. Myasthenia Gravis Scholarship™, supporting individuals impacted by myasthenia gravis (MG) including patients, caregivers, and family members who are pursuing f...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
OXB
LISTED
LSE
OXB honoured at 2025 CDMO Leadership Awards Europe in ‘Cell & Gene Therapy’ category
News Preview
Oxford, UK – 29 October 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces it has been recognised as a Champion in the ‘Cell & Gene Therapy’ category at the 2025 CDMO Leadership Awards Europe in Frankfurt. The prestigious Champion title is awarded to the highest-scoring CDMO in each category, b...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ANAB
LISTED
NASDAQ
Anaptys Announces New Positive Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis at ACR Late-Breaking Oral Presentation
News Preview
SAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced late-breaking data from the robust, global 424-patient Phase 2b trial of rosnilimab, a selective and potent pathogenic T cell depleter, in rheumatoid arthrit...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
UCB
LISTED
EURONEXT
UCB to unveil new data for RYSTIGGO® (rozanolixizumab-noli) and ZILBRYSQ®(zilucoplan) for gMG at the 2025 AANEM Annual Meeting and MGFA Scientific Session
News Preview
UCB will showcase 18 abstracts, including an oral presentation, demonstrating continued commitment to advancing targeted treatments for generalized myasthenia gravis (gMG).
Presentations include new post hoc analyses considering corticosteroid dose tapering during treatment with RYSTIGGO® (rozan...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
LEGN
LISTED
NASDAQ
Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results
News Preview
SOMERSET, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Wednesday, November 12, 2025, to review third quarter 2025 results....
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
OGI
LISTED
NASDAQ
Majority of Canadians Want Carney Government to Catch Up on Cannabis Policy
News Preview
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), Canada’s largest cannabis company by market share, today released new national polling figures, conducted on its behalf by Abacus Data showing that a clear majority of Canadians want Ottawa to modernize its approach to the legal cannabis sector.
Nearly six in ten Canadians (59%) believe the federa...
Themefolio
Profiler
Peergroup
© EQS Newswire
29.10.2025
EVT
LISTED
XETR
Bekanntgabe der Ergebnisse für die ersten neun Monate 2025 am 05. November 2025
News Preview
Hamburg, 29. Oktober 2025:
Evotec SE (Frankfurter Wertpapierbörse: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ: EVO) veröffentlicht am Mittwoch, 05. November 2025, ihre Zwischenmitteilung für die ersten neun Monate 2025.
In einer Telefonkonferenz in englischer Sprache werden die Ergebnisse und Schwerpunkte aus dem Beri......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.10.2025
EVT
LISTED
XETR
Evotec SE to announce results for the first nine months 2025 on 05 November 2025
News Preview
Hamburg, Germany, 29 October 2025:
Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ: EVO) will announce its interim statement for the first nine months 2025 on Wednesday, 05 November 2025.
The Company is going to hold a conference call to discuss the results as well as provide an update ......
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
VITR
LISTED
STO
Nomination committee of Vitrolife AB (publ) for the Annual General Meeting 2026
News Preview
GOTHENBURG, Sweden, Oct. 29, 2025 /PRNewswire/ -- In accordance with the Nomination Committee Charter adopted at the Annual General Meeting 2025, the members who, together with the Chair of the Board, constitute the Nomination Committee in preparation of the Annual General Meeting 2026 have been elected....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.10.2025
EVT
LISTED
XETR
Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025
News Preview
HAMBURG, DE / ACCESS Newswire / October 29, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) will announce its interim statement for the first nine months 2025 on Wednesday, 05 November 2025.The Company is going to hold a conference call to discuss the results as well as provi...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
NKTR
LISTED
NASDAQ
Nektar to Announce Financial Results for the Third Quarter on Thursday, November 6, 2025, After Close of U.S.-Based Financial Markets
News Preview
SAN FRANCISCO, Oct. 28, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter on Thursday, November 6, 2025, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the r...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
EHAB
LISTED
NYSE
Enhabit Announces Participation in UBS Global Healthcare Conference 2025
News Preview
Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the UBS Global Healthcare Conference 2025.
Enhabit’s President and CEO Barb Jacobsmeyer and Chief Financial Officer Ryan Solomon will participate in a fireside chat on Tuesday, Nov. 11 at 11:30 a.m. CT. The fireside chat will be...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
GNFT
LISTED
EURONEXT
GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting® 2025
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), October 28, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced its participation at the upcoming American Association for the Study of Liver D...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
DBV
LISTED
EURONEXT
DBV Technologies Reports Third Quarter 2025 Financial Results
News Preview
Châtillon, France, October 28, 2025...
Themefolio
Profiler
Peergroup
© EQS Newswire
28.10.2025
GXI
LISTED
XETR
Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen
News Preview
Gerresheimer: Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen
Industry expert with many years of experience in the sector, including around 26 years in management positions at Gerresheimer
Dietmar Siemssen to step down as CEO by mutual agreement with the Supervisory Board
New formation of the Management Board
Duesseldorf, October 2......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.10.2025
GXI
LISTED
XETR
Uwe Röhrhoff übernimmt als Interims-CEO für Dietmar Siemssen
News Preview
Gerresheimer: Uwe Röhrhoff übernimmt als Interims-CEO für Dietmar Siemssen
Industrieexperte mit langjähriger Branchenerfahrung, darunter rund 26 Jahre aus Managementpositionen bei Gerresheimer
Dietmar Siemssen legt im Einvernehmen mit dem Aufsichtsrat sein Amt als CEO nieder
Personelle Neuaufstellung des Vorstands
Düsseldorf, 28. Oktober 2025. ......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.10.2025
GXI
LISTED
XETR
Uwe Röhrhoff übernimmt als Interims-CEO für Dietmar Siemssen
News Preview
Gerresheimer AG: Uwe Röhrhoff übernimmt als Interims-CEO für Dietmar Siemssen
Düsseldorf, 28. Oktober 2025. Der Aufsichtsrat der Gerresheimer AG (ISIN: DE000A0LD6E6, "Gerresheimer"), hat Uwe Röhrhoff mit Wirkung zum 1. November 2025 als Interims-CEO in den Vorstand der Gesellschaft berufen. Er folgt auf Dietmar Siemssen, der sein Amt als CEO der ......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.10.2025
GXI
LISTED
XETR
Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen
News Preview
Gerresheimer AG: Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen
Duesseldorf, October 28, 2025. The Supervisory Board of Gerresheimer AG (ISIN: DE000A0LD6E6, "Gerresheimer") has appointed Uwe Röhrhoff as the interim CEO of the Management Board, effective November 1, 2025. He succeeds Dietmar Siemssen, who will step down as CEO of Ger......
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
TEM
LISTED
NASDAQ
Tempus to Participate in the Stifel 2025 Healthcare Conference
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced that it will participate in the Stifel 2025 Healthcare Conference on Thursday, November 13 in New York City. Jim Rogers, Chief Financial Officer at Tempus, will participate in a fireside chat at 10:00 AM ET.
The live webcast will be availab...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
RXRX
LISTED
NASDAQ
Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
News Preview
Company to host public (L)earnings call on November 5th at 8:00 am ET / 6:00 am MT / 1:00 pm GMT Company to host public (L)earnings call on November 5th at 8:00 am ET / 6:00 am MT / 1:00 pm GMT...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
CHEMM
LISTED
CPH
Upgrade of guidance
News Preview
ANNOUNCEMENT NO. 295...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
KDEV
LISTED
STO
Karolinska Development invests SEK 7.5 million to support BOOST Pharma’s continued development of BT-101 towards Phase 3
News Preview
Stockholm, Sweden – October 28, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that it has exercised its pro rata participation of SEK 7.5 million in BOOST Pharma’s latest financing. In total, BOOST Pharma’s financing, structured as a convertible loan, brings SEK 15 million to the company. The investment supports the conti...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ORNBV
LISTED
HEL
Orion Group Interim Report January–September 2025
News Preview
ORION CORPORATION INTERIM REPORT 1–9/2025 28 OCTOBER 2025 at 12:00 EET...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
BAVA
LISTED
CPH
Bavarian Nordic Provides Further Support to Mpox Outbreak in Africa through Additional Donation of Vaccines
News Preview
COPENHAGEN, Denmark, October 28, 2025 – Bavarian Nordic announced today a donation of mpox vaccines to Africa CDC to support the response to the ongoing mpox outbreak in Africa....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
XFOR
LISTED
NASDAQ
X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million
News Preview
BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR) (“X4” or the “Company”), a company driven to improve the lives of people with rare hematology diseases, today announced the closing of its previously announced underwritten public offering of 52,844,000 shares of its common stock, including the full exercise of the underw...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
CLARI
LISTED
EURONEXT
Revenue for the nine months ended 30 September 2025
News Preview
...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
SN
LISTED
LSE
Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound therapy (sNPWT) devices in orthopedic and cardiovascular surgery....
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
CTEC
LISTED
LSE
Stigma, Not Condition, Is the Biggest Barrier for 1 in 3 People Living With Chronic Conditions, According to New Convatec Research
News Preview
Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today announced the publication of a new report revealing that millions of people feel they need to hide their health conditions in plain sight. Perspectives on living with chronic conditions – research undertaken in the Uni...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
CTEC
LISTED
LSE
Stigma, Not Condition, Is the Biggest Barrier for 1 in 3 People Living With Chronic Conditions, According to New Convatec Research
News Preview
Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today announced the publication of a new report revealing that millions of people feel they need to hide their health conditions in plain sight. Perspectives on living with chronic conditions – research undertaken in the Uni...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
AMRX
LISTED
NASDAQ
Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches
News Preview
BRIDGEWATER, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced the U.S. commercial launch of Brekiya® (dihydroergotamine mesylate) injection, the first and only ready-to-use dihydroergotamine (DHE) autoinjector approved for the acute treatment of migraine with or withou...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
OXB
LISTED
LSE
OXB to participate in upcoming investor conferences and events
News Preview
OXB to participate in upcoming investor conferences and events...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Healthcare Conference
News Preview
MINNEAPOLIS, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 2025 UBS Global Healt...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
AUTL
LISTED
NASDAQ
Autolus Therapeutics Presents Clinical Data Updates at the American College of Rheumatology Convergence 2025
News Preview
Data from a Phase 1 dose confirmation clinical trial of obe-cel in severe refractory systemic lupus erythematosus will be presented....
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
SECT_B
LISTED
STO
Stockholm hospitals unify all imaging in Sectra's cloud service to boost collaboration and patient care
News Preview
LINKÖPING, Sweden, Oct. 27, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra(STO: SECT B) announces that Sweden's capital region, Region Stockholm, will expand its use of Sectra's enterprise imaging solution and transition to a fully managed cloud service. All hospitals in Re...
Themefolio
Profiler
Peergroup
© EQS Newswire
27.10.2025
EVT
LISTED
XETR
Evotec gibt Fortschritt in präklinischer Neurologie-Partnerschaft mit Bristol Myers Squibb bekannt
News Preview
Fortschritte in der präklinischen Pipeline zur Bekämpfung neurodegenerativer Erkrankungen
Evotec erhält eine Zahlung von 25 Mio. US$, um die weitere Entwicklung gemeinsamer Programme zu unterstützen
Hamburg, 27. Oktober 2025:
Evotec SE (Frankfurter Wertpapierbörse: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 5664......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.10.2025
EVT
LISTED
XETR
Evotec announces progress in preclinical neuroscience partnership with Bristol Myers Squibb
News Preview
Advances made in preclinical pipeline addressing neurodegenerative diseases
Evotec receives US$ 25 m payment to support continued progression of joint programs
Hamburg, Germany, 27 October 2025:
Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ: EVO) today announced t......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
